Cellular and T cell engager Immunotherapy
Early Absolute Lymphocyte Count after BCMA CAR-T as a Surrogate for CAR-T expansion, response, and Progression Free Survival in Multiple Myeloma
Mateo Mejia Saldarriaga, MD
Assisstant Professor
Weill Cornell Medicine
NEW YORK, New York, United States